Navigation Links
Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
Date:4/10/2008

activity of a new PI3K inhibitor PX-866 for

treatment of human glioblastoma

Abstract # 3731, Session: Imaging in Preclinical and Clinical

Therapeutics

Poster Session: Tuesday, April 15, 2008, 8:00 a.m. to

12:00 p.m. PT

- Identification of novel synergistic targets RACK-1 and galectin-1 for

rational drug combinations with PI3 Kinase inhibitors using siRNA

synthetic lethality screening

Abstract # 2761, Session: Signal Transduction and Therapeutics

Poster Session: Monday, April 14, 2008, 1:00 p.m. to

5:00 p.m. P.T.

- Phosphatidylinositol 3-kinase stimulates the proliferation of

bronchioalveolar stem cells in mouse models of oncogenic K-ras-

induced lung cancer

Abstract # 5408, Session: Stem Cells

Poster Session: Wednesday, April 16, 2008, 8:00 a.m. to

12:00 p.m. P.T.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit http://www.oncothyreon.com.

Forward Looking Statements

In order to provide Oncothyreon's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward looking, including statements related to future clinical development plans for PX-12 and PX-866. These forward-looking statements represent Oncothyreon's intentions, plans, expectations and beliefs and are based on its management's experience and assessment of historical and future trends and the application of key assumptions relating to future events an
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncothyreon announces effectiveness of shelf registration statement
2. Oncothyreon announces issuance of patent for PX-867
3. Oncothyreon to present at upcoming investment conferences
4. Oncothyreon reports full year and fourth quarter 2007 financial results
5. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
6. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
7. Oncothyreon launches new corporate website
8. Oncothyreon to present at BIO CEO & Investor Conference
9. Oncothyreon highlights corporate and clinical objectives for 2008
10. Biomira announces plan to change name to Oncothyreon
11. Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )w...ecember1stat1:45PMGMTinLondon,7:45AMUS/CST.Interes...ernetavailableat http://inve s tor.sig m a a...essthisfile. ,, AboutSigma-Aldrich: Sigma-Al....Itschemicalandbiochemicalproductsandkitsareusedin...
(Date:11/24/2009)...ia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood&...gationalnewdrugapplication(IND)foritsoralinsulinpr...atdiabetes.ThisIND,approvalallowsBiolaxytoinitiate...ordercharacteristicofhighbloodglucoseandpoor,metab...emicro-and,macro-vasculardiseases,lossofvision,kid...
(Date:11/24/2009)...FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theg...ncedthatithassubmittedaMAAtotheEuropeanMedicinesAg...ementtherapyindevelopment,forthetreatmentofType1Ga...rvelaglucerasealfathathasbeensubmitted,withpreviou...sedonaglobalsupplyshortageofthecurrentlyapprovedan...
(Date:11/24/2009)...stracts Service (CAS), the global expert on chemic... is now the world,s leading producer of patent inv...pan,s patent office, the World Intellectual Proper...nt and Trademark Office (USPTO) for more than a de...and exceeded Japan for the first time on a monthly...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
..., , , , , For cleanup of DNA f... , , , Applicati... , , Format: , S...roughput: , 124 samples, , ...100 bp 10 kb, , , ...
..., , , , , For purification of ... , , , Applicatio..., , , Format: , ... Throughput: , 124 samples, ... 70 bp 4 kb*, , , ...
... , , , , , Ni-NTA Superflow ...s-tagged , protein preparations to be perfo...kstation. Using cleared lysates from bacterial cul...rotein per column can be purified under native or ...protocols. The increase in yield means that , ...
Other Biology Technology:Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 2Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 3Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 4
(Date:11/23/2009)...y-associated strain of the deadly superbug MRSAan ...n antibioticsposes a far greater health threat tha...itals, according to a study in the December issue ...reat is easily picked up in fitness centers, schoo...overall burden of MRSA within hospitals, the repor...
(Date:11/23/2009)...0 participants gathered this week for the seventh ...conference. This year,s topic, "Synthetic Biology,...cal researchers to explore the engineering, scient...ield of synthetic biology. , Bonnie L. Bassler, ...sity and this year,s conference chair, challenged ...
(Date:11/23/2009)...ng some of the highest resolution images of peptid...a deeper understanding how biomolecules manipulate...new treatment for kidney stones using biomolecules...nline edition of the journal Proceedings of the N...s interact with mineral surfaces by accelerating, ...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Moms to be warned over use of fetal heart rate monitors 54954 1Type 1 diabetes linked to immune response to wheat 54951 1Type 1 diabetes linked to immune response to wheat 54951 2MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 1MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 2MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 3
...r brains when we learn and remember" Are memories ... an inscription permanently on a clay tablet" Pro...urobiology Department, and his colleagues are chal...he process of storing long-term memories is much m...ne that must run constantly to keep memories going...
...ng out to start a family of their own, members of ... a relative raise their young. Now, researchers re...istic tendencies are most common among species tha...n year is virtually impossible to predict. The fin...nt Biology, a publication of Cell Press. , When t...
...ng having kids to help raise the offspring of othe...e, but many African starlings have adopted this st...heir savanna habitats, according to a new study by...niversity biologists. It appears in the Aug. 21 is...or, called cooperative breeding, is typical of man...
Other Biology News:Memory machine 2Uncertainty drives the evolution of 'cooperative breeding' in birds 2Savanna habitat drives birds, and perhaps others, to cooperative breeding 2Savanna habitat drives birds, and perhaps others, to cooperative breeding 3Savanna habitat drives birds, and perhaps others, to cooperative breeding 4
...T-loxP template is designed to allow kanamycin/ne...ls, respectively. It combines a prokaryotic promo...n E.coli with a eukaryotic promoter (PGK) for ex.... The prokaryotic promoter gb2 is a slightly modi...
...PYREX Fernbach-style culture flask is designed for...a to volume ratio. It can also be used in serum pr...es to achieve maximal oxygen transfer to culture m...and accepts cotton plugs or No. 13 rubber stoppers...
...provides a simple and efficient means for isolatio...exin V magnetic beads (MagBeads). Annexin V is a C...gh affinity for phosphatidylseri The Apoptotic Ce...eans for isolation of apoptotic cells or removal o...
...meter, 7 inch long PYREX NMR tubes are made from q...round joints, valves, and vacuum racks. They are d...300 to 500MHz. They have an O.D. of 4.97 + 0.000-0...NMR tubes can be used with the PYREX Microcell sys...
Biology Products: